<DOC>
	<DOC>NCT00687505</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the safety and tolerability of FP-1039, a new biologic treatment for cancer.</brief_summary>
	<brief_title>Safety Study of FP-1039 To Treat Cancer</brief_title>
	<detailed_description />
	<criteria>Subjects with metastatic or locally advanced unresectable solid tumors for which standard curative or supportive measures do not exist or are no longer effective Male or female 18 years of age or older Presence or history of melanoma Primary brain tumor Presence or history of glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>